doxazosin has been researched along with Prostatism in 8 studies
Doxazosin: A prazosin-related compound that is a selective alpha-1-adrenergic blocker.
doxazosin : A member of the class of quinazolines that is quinazoline substituted by an amino group at position 4, methoxy groups at positions 6 and 7 and a piperazin-1-yl group at position 2 which in turn is substituted by a 2,3-dihydro-1,4-benzodioxin-2-ylcarbonyl group at position 4. An antihypertensive agent, it is used in the treatment of high blood pressure.
Prostatism: Lower urinary tract symptom, such as slow urinary stream, associated with PROSTATIC HYPERPLASIA in older men.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Both doxazosin and terazosin were significantly more likely than finasteride to improve peak urine flow and nocturia, versus finasteride." | 6.46 | Finasteride for benign prostatic hyperplasia. ( Fink, HA; Macdonald, R; Rutks, I; Tacklind, J; Wilt, TJ, 2010) |
| "Doxazosin was given for 30 days, and at the second visit IPSS, NIH-CPSI and IIEF-5 scores, Qmax and PMR were once more analysed." | 5.37 | Effectiveness of doxazosin on erectile dysfunction in patients with lower urinary tract symptoms. ( Aktas, A; Eryildirim, B; Faydaci, G; Kuyumcuoglu, U; Tarhan, F; Tuncer, M, 2011) |
| "Both doxazosin and terazosin were significantly more likely than finasteride to improve peak urine flow and nocturia, versus finasteride." | 2.46 | Finasteride for benign prostatic hyperplasia. ( Fink, HA; Macdonald, R; Rutks, I; Tacklind, J; Wilt, TJ, 2010) |
| "Doxazosin was given for 30 days, and at the second visit IPSS, NIH-CPSI and IIEF-5 scores, Qmax and PMR were once more analysed." | 1.37 | Effectiveness of doxazosin on erectile dysfunction in patients with lower urinary tract symptoms. ( Aktas, A; Eryildirim, B; Faydaci, G; Kuyumcuoglu, U; Tarhan, F; Tuncer, M, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 7 (87.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barkin, J | 1 |
| Diles, D | 1 |
| Franks, B | 1 |
| Berner, T | 1 |
| Fusco, F | 1 |
| Palmieri, A | 1 |
| Ficarra, V | 1 |
| Giannarini, G | 1 |
| Novara, G | 1 |
| Longo, N | 1 |
| Verze, P | 1 |
| Creta, M | 1 |
| Mirone, V | 1 |
| Liu, Q | 1 |
| Zhu, Y | 1 |
| Liu, J | 1 |
| Qi, J | 1 |
| Kang, J | 1 |
| Kaplan, SA | 1 |
| Lavallée, LT | 1 |
| Dahm, P | 1 |
| Breau, RH | 1 |
| Tacklind, J | 1 |
| Fink, HA | 1 |
| Macdonald, R | 1 |
| Rutks, I | 1 |
| Wilt, TJ | 1 |
| Faydaci, G | 1 |
| Kuyumcuoglu, U | 1 |
| Eryildirim, B | 1 |
| Aktas, A | 1 |
| Tarhan, F | 1 |
| Tuncer, M | 1 |
| Liao, CH | 1 |
| Lin, VC | 1 |
| Chung, SD | 1 |
| Kuo, HC | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Prophylactic Tamsulosin in Prevention of Post-operative Urinary Retention in Men After Transanal Endoscopic Microsurgery: A Multicenter Randomized, Double-blind, Placebo-controlled Clinical Trial[NCT03314025] | Phase 2 | 158 participants (Anticipated) | Interventional | 2017-10-06 | Recruiting | ||
| The Effect of Traditional Chinese Medicine VGH-BPH1 on Patients With Benign Prostatic Hyperplasia: A Double-blinded Randomized Placebo-controlled Cross-over Study[NCT03829904] | Phase 1/Phase 2 | 23 participants (Actual) | Interventional | 2019-03-06 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for doxazosin and Prostatism
| Article | Year |
|---|---|
α1-Blockers Improve Benign Prostatic Obstruction in Men with Lower Urinary Tract Symptoms: A Systematic Review and Meta-analysis of Urodynamic Studies.
Topics: Adrenergic alpha-1 Receptor Antagonists; Clinical Trials as Topic; Doxazosin; Humans; Indoles; Male; | 2016 |
Current role of alpha-blockers in the treatment of benign prostatic hyperplasia.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Clinical Trials as Topic; Doxazosin; Drug Administration | 2008 |
Finasteride for benign prostatic hyperplasia.
Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Disease Progression; Doxazosin; Drug The | 2010 |
5 other studies available for doxazosin and Prostatism
| Article | Year |
|---|---|
Alpha blocker monotherapy versus combination therapy with antimuscarinics in men with persistent LUTS refractory to alpha-adrenergic treatment: patterns of persistence.
Topics: Administrative Claims, Healthcare; Adrenergic alpha-Antagonists; Aged; Benzofurans; Doxazosin; Drug | 2015 |
Ultrasound image features of intravesical prostatic protrusion indicated failure of medication therapy of finasteride and doxazosin in patients with benign prostatic hyperplasia (LUTS/BPH).
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Doxazosin; Drug Therapy, Combination; Finasteride; Hu | 2017 |
Evidence-based urology in practice: composite endpoints.
Topics: 5-alpha Reductase Inhibitors; Doxazosin; Drug Therapy, Combination; Endpoint Determination; Evidence | 2010 |
Effectiveness of doxazosin on erectile dysfunction in patients with lower urinary tract symptoms.
Topics: Adrenergic alpha-1 Receptor Antagonists; Doxazosin; Erectile Dysfunction; Humans; Male; Middle Aged; | 2011 |
Therapeutic effect of α-blockers and antimuscarinics in male lower urinary tract symptoms based on the International Prostate Symptom Score subscore ratio.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Benzhydryl Compounds; Cresols; Doxazosin; Feasibility | 2012 |